Brewin Dolphin Wealth Management’s Celgene Corp CELG Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$39.7K	–	203
2019 Q3	$39.7K	Hold	400	–	–	0.02%	119
2019 Q2	$37K	Hold	400	–	–	0.02%	124
2019 Q1	$37.7K	Hold	400	–	–	0.02%	119
2018 Q4	$25.6K	Hold	400	–	–	0.02%	128
2018 Q3	$35.8K	Hold	400	–	–	0.02%	124
2018 Q2	$31.8K	Sell	400 -3,700	-90%	-$307K	0.02%	126
2018 Q1	$366K	Hold	4,100	–	–	0.23%	57
2017 Q4	$428K	Buy	+4,100	New	+$463K	0.27%	55

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Brewin Dolphin Wealth Management's CELG Position: Q4 2019 in Review

Brewin Dolphin Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 400 shares — an estimated $39.7K sold.

Brewin Dolphin Wealth Management first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $428K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Brewin Dolphin Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Brewin Dolphin Wealth Management sold 400 Celgene Corp shares in Q4 2019, an estimated $39.7K.
Brewin Dolphin Wealth Management first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
Brewin Dolphin Wealth Management's Celgene Corp position peaked at $428K in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brewin Dolphin Wealth Management's 13F filing for Q4 2019, filed 9 Nov 2023.